+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Palatin Technologies Inc - logo

Palatin Technologies is a biopharmaceutical company that develops targeted, receptor-specific peptide therapeutics for the treatment of various diseases in the United States. The company’s leading product is Bremelanotide, which is used to treat hypoactive sexual desire disorder (HSDD). It has completed pivotal Phase 3 clinical trials. Palatin also has development programs or drug candidates for inflammatory disease indications, heart failure and fibrosis. It was founded in 1986 and is based in Cranbury, New Jersey.

From
Diabetic Retinopathy - Pipeline Review, H2 2020 - Product Thumbnail Image

Diabetic Retinopathy - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 358 Pages
  • Global
From
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2020 - Product Thumbnail Image

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 631 Pages
  • Global
From
Myocardial Fibrosis - Pipeline Review, H1 2020 - Product Thumbnail Image

Myocardial Fibrosis - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 87 Pages
  • Global
From
From
From
From
Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H2 2020 - Product Thumbnail Image

Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 359 Pages
  • Global
From
From
Melanocyte Stimulating Hormone Receptor - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanocyte Stimulating Hormone Receptor - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 80 Pages
  • Global
From
Loading Indicator